Wafra Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-665,539
Closed -$23.5M 80
2018
Q4
$23.5M Buy
665,539
+335,822
+102% +$12.2M 0.92% 14
2018
Q3
$12.7M Hold
329,717
0.43% 42
2018
Q2
$10.8M Hold
329,717
0.4% 44
2018
Q1
$9.01M Sell
329,717
-251,581
-43% -$6.84M 0.41% 50
2017
Q4
$14.4M Buy
581,298
+167,119
+40% +$4.61M 0.66% 29
2017
Q3
$12.1M Sell
414,179
-35,207
-8% -$972K 0.59% 39
2017
Q2
$12.5M Sell
449,386
-14,979
-3% -$398K 0.63% 38
2017
Q1
$11.5M Buy
464,365
+135,004
+41% +$3.28M 0.59% 39
2016
Q4
$7.12M Buy
329,361
+320,618
+3,667% +$7M 0.39% 54
2016
Q3
$208K Buy
+8,743
New +$209K 0.02% 76

Other funds holding BSX

Wafra Inc's BSX Position: Q1 2019 in Review

Wafra Inc sold out of Boston Scientific (BSX) in Q1 2019, closing a stake of 665,539 shares — an estimated $23.5M sold.

Wafra Inc first reported a position in BSX in Q3 2016 and held it in 10 quarters. The position peaked at $23.5M in Q4 2018. 789 funds tracked by Wall St. Rank hold BSX as of Q1 2019.

  • Wafra Inc reported no remaining Boston Scientific position as of Q1 2019 after selling out during the quarter.
  • Wafra Inc sold 665,539 Boston Scientific shares in Q1 2019, an estimated $23.5M.
  • Wafra Inc first reported a position in Boston Scientific in Q3 2016 and held it in 10 quarters.
  • Wafra Inc's Boston Scientific position peaked at $23.5M in Q4 2018.
  • 789 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2019.

Based on Wafra Inc's 13F filing for Q1 2019, filed 13 May 2019.